4//SEC Filing
Morris-Irvin Dwain 4
Accession 0001185185-22-000271
CIK 0001039466other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 10:09 AM ET
Size
8.4 KB
Accession
0001185185-22-000271
Insider Transaction Report
Form 4
Morris-Irvin Dwain
Chief Executive Officer
Transactions
- Other
Series B Preferred Stock, $0.01 par value per share
2022-03-14+600→ 600 total(indirect: By LLC) - Other
Series B Preferred Stock, $0.01 par value
2022-03-14+600→ 600 total(indirect: By LLC)Exercise: $0.00→ Common Stock, no par value (6,000,000 underlying)
Holdings
- 1,800,000
Common Stock, no par value
Footnotes (2)
- [F1]Effective March 14, 2022, Irvin Consulting, LLC, a California limited liability company owned and controlled by to Dr. Irvin, purchased in a private transaction 600 shares of Series B preferred stock from TN3, LLC. Irving Consulting paid a total of $7,223 for the preferred shares.
- [F2]Each share of Series B preferred stock is currently convertible at the option of the holder into 10,000 shares of common stock and entitles the holder to cast 40,000 votes on any action presented to shareholders. The preferred stock conversion feature has no expiration date.
Documents
Issuer
NovAccess Global Inc.
CIK 0001039466
Entity typeother
Related Parties
1- filerCIK 0001830095
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 10:09 AM ET
- Size
- 8.4 KB